Logo image of RKLB

ROCKET LAB USA INC (RKLB) Stock Fundamental Analysis

NASDAQ:RKLB - Nasdaq - US7731221062 - Common Stock - Currency: USD

18.8  +0.14 (+0.75%)

After market: 18.5807 -0.22 (-1.17%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to RKLB. RKLB was compared to 65 industry peers in the Aerospace & Defense industry. RKLB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RKLB shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RKLB had negative earnings in the past year.
In the past year RKLB has reported a negative cash flow from operations.
RKLB had negative earnings in each of the past 5 years.
In the past 5 years RKLB always reported negative operating cash flow.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

RKLB has a worse Return On Assets (-16.06%) than 72.31% of its industry peers.
The Return On Equity of RKLB (-49.73%) is worse than 67.69% of its industry peers.
Industry RankSector Rank
ROA -16.06%
ROE -49.73%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

The Gross Margin of RKLB (26.63%) is better than 63.08% of its industry peers.
The Profit Margin and Operating Margin are not available for RKLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RKLB has been increased compared to 1 year ago.
Compared to 5 years ago, RKLB has more shares outstanding
The debt/assets ratio for RKLB is higher compared to a year ago.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RKLB has an Altman-Z score of 6.21. This indicates that RKLB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.21, RKLB belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
RKLB has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
RKLB has a Debt to Equity ratio of 1.06. This is in the lower half of the industry: RKLB underperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z 6.21
ROIC/WACCN/A
WACC9.32%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

RKLB has a Current Ratio of 2.04. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of RKLB (2.04) is comparable to the rest of the industry.
A Quick Ratio of 1.69 indicates that RKLB should not have too much problems paying its short term obligations.
The Quick ratio of RKLB (1.69) is better than 70.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.69
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.63% over the past year.
RKLB shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.34%.
RKLB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 55.23% yearly.
EPS 1Y (TTM)2.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)78.34%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%120.68%

3.2 Future

The Earnings Per Share is expected to grow by 40.75% on average over the next years. This is a very strong growth
RKLB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.03% yearly.
EPS Next Y12.7%
EPS Next 2Y39.66%
EPS Next 3Y40.75%
EPS Next 5YN/A
Revenue Next Year37.64%
Revenue Next 2Y44.19%
Revenue Next 3Y43.35%
Revenue Next 5Y35.03%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RKLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RKLB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

RKLB's earnings are expected to grow with 40.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.66%
EPS Next 3Y40.75%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RKLB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKET LAB USA INC

NASDAQ:RKLB (3/7/2025, 8:00:02 PM)

After market: 18.5807 -0.22 (-1.17%)

18.8

+0.14 (+0.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)N/A N/A
Inst Owners49.02%
Inst Owner Change-4.84%
Ins Owners0.64%
Ins Owner Change28.9%
Market Cap8.53B
Analysts78
Price Target25.53 (35.8%)
Short Float %10.87%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.04%
Min EPS beat(2)3.88%
Max EPS beat(2)12.21%
EPS beat(4)4
Avg EPS beat(4)13.93%
Min EPS beat(4)3.88%
Max EPS beat(4)22.86%
EPS beat(8)6
Avg EPS beat(8)7.2%
EPS beat(12)8
Avg EPS beat(12)5.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.07%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)0.46%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-4.26%
Max Revenue beat(4)0.46%
Revenue beat(8)2
Avg Revenue beat(8)-1.71%
Revenue beat(12)5
Avg Revenue beat(12)0.01%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.81%
PT rev (3m)27.79%
EPS NQ rev (1m)-0.32%
EPS NQ rev (3m)-0.32%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.54
P/FCF N/A
P/OCF N/A
P/B 24.56
P/tB 37.16
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.87
BVpS0.77
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.06%
ROE -49.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.63%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 199.36%
Cap/Sales 15.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.69
Altman-Z 6.21
F-Score5
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y12.7%
EPS Next 2Y39.66%
EPS Next 3Y40.75%
EPS Next 5YN/A
Revenue 1Y (TTM)78.34%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%120.68%
Revenue Next Year37.64%
Revenue Next 2Y44.19%
Revenue Next 3Y43.35%
Revenue Next 5Y35.03%
EBIT growth 1Y-6.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.51%
EBIT Next 3Y50.95%
EBIT Next 5Y39.31%
FCF growth 1Y24.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.55%
OCF growth 3YN/A
OCF growth 5YN/A